Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has The Smart Inhalers Market Growth Evolved From 2024 To 2025, And What’s Ahead?
Over the past few years, the market size for smart inhalers has significantly expanded. The market, initially valued at $1.65 billion in 2024, is expected to reach $1.8 billion by 2025, exhibiting a compound annual growth rate (CAGR) of 9.5%. The growth factor during the historical period can be linked to the rise in adherence to medical guidelines, a shift towards patient-centric healthcare, and an escalating demand for integrated healthcare devices.
In the coming years, the smart inhalers market is set to experience significant expansion. The market is projected to reach $2.62 billion in 2029, with a compound annual growth rate (CAGR) of 9.8%. Factors contributing to this predicted growth include the increasing incidence of chronic respiratory diseases (CRDs), the rising demand for home healthcare services, and the escalating adoption of digital healthcare solutions. Additionally, the forecast period is expected to see pivotal trends like the progression of technology in smart inhalers, the implementation of big data analytics, the utilization of chip-on-sensors, and the evolution in sensor technology.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=14196&type=smp
What are the Fundamental Drivers and Innovations Shaping the Smart Inhalers Market?
The anticipated surge in chronic respiratory diseases (CRDs) is predicted to propel the expansion of the smart inhaler market. CRDs involve various enduring ailments that impact the lung’s airways and other components. These smart inhalers aid in the management of chronic respiratory illnesses like asthma and COPD by monitoring usage and providing alerts for skipped doses, ensuring regular medication intake for symptom relief and exacerbation prevention. For example, the 2022 National Health Survey by the Australian Bureau of Statistics, a national statistical organization based in Australia, noted that around 8.5 million Australians, equating to 34% of the population, deal with chronic respiratory disorders. Of this, approximately 2.8 million individuals (11%) experience asthma, a disease marked by wheezing and breathlessness due to inflammation of airways. Additionally, nearly 638,000 individuals (2.5%) are believed to suffer from chronic obstructive pulmonary disease (COPD), typified by continuous airflow restriction and potent breathing issues. Both conditions pose significant health obstacles, affecting day-to-day tasks and overall life quality. Consequently, the escalating prevalence of chronic respiratory diseases (CRDs) is fueling the growth of the smart inhaler market.
How Is the Smart Inhalers Market Segmented?
The smart inhalersmarket covered in this report is segmented –
1) By Type: Dry Powdered Inhalers (DPIs); Metered Dose Inhalers (MDIs)
2) By Indication: Asthma; Chronic Obstructive Pulmonary Disease (COPD); Other Indications
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
4) By End-User: Hospitals; Homecare Settings; Other End-Users
Subsegments:
1) By Dry Powdered Inhalers (DPIs): Single-Dose DPIs; Multi-Dose DPIs
2) By Metered Dose Inhalers (MDIs): Conventional MDIs; Smart MDIs With Connectivity Features
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=14196&type=smp
Which Regions Are Driving the Next Phase of the Smart Inhalers Market Growth?
North America was the largest region in the smart inhalers market in 2024. The regions covered in the smart inhalers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Key Trends Are Shaping the Future of the Smart Inhalers Market?
Leading businesses in the smart inhaler market are innovating with cutting-edge technologies like digital respiratory solutions to accommodate more clients, enhance sales, and increase revenue. Digital respiratory health solutions refer to tech-driven interventions or platforms that assist in the management and treatment of respiratory health conditions. In February 2022, an example of this was demonstrated by Aptar Pharma. This U.S.-based pharmaceutical services organization introduced the HeroTracker Sense, a unique digital respiratory health solution that serves as a supplementary connected device. This unique solution converts regular metered-dose inhalers (MDIs) into digitally connected health devices. It’s particularly created for patients worldwide dealing with chronic respiratory illnesses such as asthma, COPD, cystic fibrosis, and COVID-19 related conditions. Its primary objective is to improve patient lives by upgrading MDIs. By attaching the HeroTracker Sense to an MDI canister, patients get premium features, like sensors that monitor inhalation synchronization, flow velocity, and duration. These details are available via a companion application, which provides medication reminders with date and time stamps and alerts for environmental changes, like humidity and temperature fluctuations. The device seeks to augment patient compliance with prescribed treatments by facilitating informed and compliant drug consumption.
View the full report here:
https://www.thebusinessresearchcompany.com/report/smart-inhalers-global-market-report
How Is the Smart Inhalers Market Defined and What Are Its Core Parameters?
Smart inhalers refer to medical devices that integrate connectivity with a mobile app, typically via Bluetooth. It is used to enhance the user experience and provide more personalized treatment decisions for individuals with chronic lung conditions such as asthma and chronic obstructive pulmonary disease (COPD).
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14196
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model